Lingotto Investment Management LLP purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 189,200 shares of the company’s stock, valued at approximately $2,543,000. Lingotto Investment Management LLP owned 0.08% of Oscar Health at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in OSCR. Wealth Enhancement Advisory Services LLC grew its position in Oscar Health by 7.5% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock valued at $255,000 after acquiring an additional 844 shares during the last quarter. KBC Group NV grew its holdings in shares of Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock worth $97,000 after purchasing an additional 1,328 shares during the last quarter. Allspring Global Investments Holdings LLC increased its stake in Oscar Health by 1.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 109,074 shares of the company’s stock worth $2,313,000 after buying an additional 1,866 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Oscar Health by 9.2% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company’s stock valued at $561,000 after buying an additional 2,236 shares in the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in Oscar Health by 28.2% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 21,968 shares of the company’s stock valued at $295,000 after buying an additional 4,838 shares during the period. 75.70% of the stock is currently owned by institutional investors.
Oscar Health Stock Up 2.5 %
Shares of NYSE OSCR opened at $15.65 on Wednesday. Oscar Health, Inc. has a 12-month low of $12.43 and a 12-month high of $23.79. The stock’s fifty day simple moving average is $14.89 and its two-hundred day simple moving average is $16.64. The stock has a market capitalization of $3.87 billion, a PE ratio of -782.01 and a beta of 1.73. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.
Wall Street Analyst Weigh In
OSCR has been the topic of a number of research reports. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target for the company. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $21.56.
Read Our Latest Research Report on Oscar Health
Insider Activity
In other news, CFO Richard Scott Blackley sold 25,279 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $457,044.32. Following the completion of the sale, the chief financial officer now owns 881,841 shares of the company’s stock, valued at $15,943,685.28. This trade represents a 2.79 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Victoria Baltrus sold 8,078 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the transaction, the chief accounting officer now owns 146,036 shares in the company, valued at approximately $2,640,330.88. This trade represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 78,610 shares of company stock worth $1,421,269. Corporate insiders own 25.11% of the company’s stock.
About Oscar Health
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories
- Five stocks we like better than Oscar Health
- Insider Buying Explained: What Investors Need to Know
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- The 3 Best Fintech Stocks to Buy Now
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Consumer Discretionary Stocks Explained
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.